Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

NHBT0000188_032 - Letter from Dr Harold Gunson to all Regional Transfusion Directors - 25 Aug 1989

Published on: 16 October, 2023

NHBT0000188_033 - Minutes of the meeting of the National Directorate of the NBTS National Management Committee

Published on: 15 September, 2023

NHBT0000188_038 - Letter from Dr Gunson to Mr Canavan - 01 Sep 1989

Published on: 15 September, 2023

NHBT0000188_039 - Letter from Dr Gunson to Mr Follet - 01 Sep 1989

Published on: 15 September, 2023

NHBT0000188_142 - Letter from Jean Harrison to Dr H H Gunson - 22 Dec 1989

Published on: 15 September, 2023

NHBT0000188_144 - Report of a Hepatitis C Trial

Published on: 15 September, 2023

NHBT0000189_050 - Guidelines for planning the Implementation of AntiHCV Testing of Blood and components for transfusion - 08 Feb 1990

Published on: 15 September, 2023

NHBT0000189_131 - Letter from Ruthven Mitchell to Professor Cash - 14 May 1990

Published on: 15 September, 2023

MHRA0024538 - Memo from Andy Hollebon to Mr Holden - 11 Apr 1995

Published on: 15 September, 2023

MHRA0024551 - Email from Charles Lister to Darren Murphy - 25 Nov 1999

Published on: 15 September, 2023

MHRA0024712 - Lords oral questions briefing pack - 05 Mar 2009

Published on: 09 May, 2024

MHRA0026440_003 - Appendix to Committee on Safety of Medicines SubCommittee on Safety Efficacy and Adverse Reactions

Published on: 15 September, 2023

MHRA0033317_014 - Examination of samples of Proplex - 07 Jun 1978

Published on: 15 September, 2023

MHRA0033319_041 - Letter from Miss Aileen Simkins to Immuno Ltd - 05 Aug 1987

Published on: 09 May, 2024

MHRA0033322_006 - Letter from Serological Products Ltd to Dr Thomas - 23 Aug 1974

Published on: 15 September, 2023

MHRA0033773 - Additional Notes for Guidance Biological Medicinal Products - 01 Jan 1968

Published on: 09 May, 2024

MHRA0034569_017 - Absence of AntiHuman Immunodeficiency virus types 1 and 2 Seroconversion after the treatment of Hemophilia A or Von Willebrands Disease with pasteurized factor VIII concentrate - 26 Oct 1989

Published on: 15 September, 2023

MHRA0034569_018 - Monitoring Blood Donors for HIV2 infection by testing AntiHIV 1 Reactive Sera - 27 Nov 1989

Published on: 15 September, 2023

MHRA0034569_019 - Inactivation of HIV2 by solvent detergent treatment - 01 Jan 1990

Published on: 15 September, 2023

MHRA0034594_015 - Draft CMO letter on vCJD - 21 Jun 1996

Published on: 15 September, 2023

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2848
  • Page 2849
  • Page 2850
  • Page 2851
  • Current page 2852
  • Page 2853
  • Page 2854
  • Page 2855
  • Page 2856
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.